Austin, TX – Director and 10% owner Brian N. Sheth, alongside multiple affiliated Haveli entities, has significantly expanded his indirect ownership position in Blend Labs, Inc. (NASDAQ:BLND). Between June 11 and June 15, 2026, these parties acquired a total of 1,156,928 shares of the company's Class A Common Stock. The total value of these acquisitions was approximately $1,991,365, with individual share prices ranging from $1.6976 to $1.7405.
This wave of insider buying arrives as Blend Labs stock trades at $1.68, reflecting a substantial decline of roughly 45% over the preceding six months. According to InvestingPro analysis, the current valuation may present an opportunity, noting that the company maintains a current ratio of 1.81 and has demonstrated revenue growth of 7.4%.
Transaction Details and Ownership Structure
The acquisitions were primarily executed by Haveli Brooks Aggregator, L.P., which directly holds the securities. The corporate structure involves several layers: Haveli Investments Software Fund I GP, LLC serves as the general partner of Haveli Brooks Aggregator, L.P. Whanau Interests LLC acts as the sole member of Haveli Investments Software GP, with Mr. Sheth serving as the managing member of Whanau Interests LLC. Additional entities involved in this ownership structure include Haveli Software Management LLC, Haveli Investment Management LLC, and Haveli Investments, L.P. Due to these interconnected relationships, Mr. Sheth and the various Haveli entities are deemed to share voting and dispositive power over the acquired securities.
The transaction timeline reveals a phased acquisition strategy. On June 11, 2026, 250,000 shares were acquired at a weighted average price of $1.7405 per share, with individual transaction prices ranging from $1.705 to $1.785. The following day, June 12, 2026, an additional 256,928 shares were purchased at a weighted average price of $1.6976 per share, with prices ranging from $1.6744 to $1.73. The final reported acquisition occurred on June 15, 2026, involving 650,000 shares at a weighted average price of $1.7232, within a range of $1.705 to $1.75.
Following these transactions, the Haveli entities and Mr. Sheth indirectly hold a total of 18,693,657 shares of Blend Labs Class A Common Stock. Additionally, Mr. Sheth indirectly holds 130,000 shares through a family trust where his spouse serves as the trustee.
Financial Performance and Market Context
These insider transactions follow Blend Labs Inc.'s report of its first-quarter 2026 financial results, which displayed mixed performance indicators. The company achieved revenue of $30.8 million, surpassing the consensus estimate of $30.0 million and marking a 15% increase from the previous year. However, earnings per share (EPS) from continuing operations were reported at $0.00, aligning with consensus estimates but missing the forecast of $0.01.
In response to these results, Citizens, an analyst firm, lowered its price target for Blend Labs from $5.00 to $4.00, while maintaining a Market Outperform rating. Meanwhile, BLender Financial Technologies announced a new partnership with Q2 Software, Inc. to market the Q2 Symphonix cloud-based financial platform in Israel. This collaboration aims to provide solutions for managing credit, deposits, and payments, tailored to meet local market requirements and regulatory standards.
Key Points
- Director Brian Sheth and Haveli entities purchased 1,156,928 shares of BLND for approximately $1.99 million between June 11 and June 15, 2026.
- The acquisitions bring the total indirect stake held by Sheth and the Haveli entities to over 18.6 million shares, reflecting significant confidence in the software provider.
- Blend Labs reported Q1 2026 revenue of $30.8 million, beating estimates by $0.8 million and showing 15% year-over-year growth.
Risks and Uncertainties
- The stock has declined approximately 45% over the past six months, indicating potential volatility and downward pressure in the fintech sector.
- Earnings per share from continuing operations missed the forecast of $0.01, reporting at $0.00, which may impact investor sentiment regarding profitability.
- Analyst price targets have been reduced from $5.00 to $4.00, suggesting cautious outlooks despite the revenue beat.